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Abstract
Background: Initiating tobacco use in adolescence increases the risk of nicotine dependence and continued
smoking. Physician screening for tobacco use increases the odds of physicians intervening with patients who
smoke; However, without appropriate follow-through by the physician, screening for tobacco use is not enough to
significantly increase cessation rates. Given the critical phase of development adolescence poses in tobacco use
and evidence that physician intervention improves adult cessation efforts, we sought to examine physician tobacco
use screening and advice to quit among adolescents (12–17 years).
Methods: Using data from the 2013 National Survey on Drug Use and Health (NSDUH), we examined the prevalence
and correlates of tobacco use screening in adolescent respondents who reported visiting their physician within
the past year (N = 12,798). Multivariable logistic regression analyses explored the relationship between tobacco
use screening and physician advice to quit in a sub-set of the sample who reported on physician advice to quit
(n = 1,868), controlling for sociodemographics, cigarette use, and substance use and screening.
Results: Only 49% of adolescents who visited a physician within the past year reported being screened for tobacco
use. Adolescents who were screened by their physician were predominantly female (56.6%), White (60.1%), in late
adolescence (83.0%), and covered by private health insurance (63.8%). Screening for tobacco use was highly correlated
with physician advice to quit smoking, controlling for sociodemographic characteristics and cigarette use; this
relationship was attenuated, but remained significant, after screening for alcohol and marijuana were added to the
model. Hispanic adolescents were significantly less likely to receive physician advice to quit in all multivariable models.
Conclusions: Our findings suggest missed opportunities for youth tobacco use prevention and cessation efforts in the
clinical setting. Further research is needed to better facilitate an open dialogue on tobacco use between physicians and
their adolescent patients.
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Background
Adolescence marks a developmental period in which there
are increases in experimentation [1] and regular use of to-
bacco [2]. An estimated 5,700 people per day initiated
smoking cigarettes in 2013 [3]. Adolescents (12–17 years)
accounted for half of all initiates in that year, and 7.8% of
adolescents reported past 30-day tobacco product use [3].
Initiating tobacco use in adolescence increases the risk of
nicotine dependence and continued smoking [4–7]. Thus,
tobacco prevention and cessation interventions may have
a greater impact in adolescence than in adulthood when
risk behaviors are more established. However, the pro-
portion of past-year quit attempts among adolescent
smokers decreased from 57.4% in 2001 to 48% in 2013
[8] suggesting that tobacco cessation efforts are not ef-
fectively reaching adolescent smokers.
Systematic reviews and meta-analyses of tobacco ces-
sation interventions show that the more successful in-
terventions consist of physicians and/or non-physicians
engaged in one-on-one interactions as a means of tailoring
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efforts to the specific cessation needs of the smoker
[9–11]. This individualized approach starts with identify-
ing an individual’s smoking status. Screening patients for
tobacco use allows physicians to identify the appropriate
intervention - promoting quitting among current smokers,
preventing relapse in former smokers, or encouraging
never smokers to continue abstinence [12].
Physician screening for tobacco use increases the odds
three-fold of physicians intervening with patients who
smoke; However, without appropriate follow through by
the physician, screening for tobacco use is not enough to
significantly increase cessation rates [12]. The 2008 up-
date to the U.S. Public Health Service Clinical Practice
Guideline for Treating Tobacco Use and Dependence
found it essential that physicians identify the tobacco
use status of patients and intervene with all tobacco
users identified [12]. Even brief physician advice lasting
less than 3 min has resulted in a significant increase in
quit rates among adult smokers compared to those who
received no advice [12, 13].
Despite evidence supporting physician-based tobacco
prevention and cessation interventions in adolescents,
data from the 2011 National Youth Tobacco Survey
shows only 20.8% of middle and high school students
who visited a physician in the past 12 months were both
screened for tobacco use and advised to quit [14]. Evi-
dence suggests the rates of physician screening and advice
to quit may differ among particular racial and ethnic
groups. Data from the Memphis Health Project, a longitu-
dinal study of smoking in adolescents in the mid-South,
found that in a primarily African American sample of 11th
graders (82.9%), 28.9% of adolescents sampled were
both screened for tobacco use and advised to quit by a
physician [15].
To our knowledge, there is no recent data available on
physician screening for tobacco use and advice to quit in
a nationally representative sample of adolescents. Given
the critical phase of development adolescence poses in
tobacco use, and evidence that face-to-face interventions
can improve smoking outcomes, this study used data from
a recent national survey to examine physician tobacco use
screening and advice to quit among adolescents who re-
ported visiting a physician in the past 12 months.
Methods
Subjects and data collection
The National Survey on Drug Use and Health (NSDUH)
is the primary source for population estimates of sub-
stance use and health-related behaviors among the U.S.
general population. A detailed description of the survey
methodology is reported elsewhere [3]. Briefly, the NSDUH
uses a state-based design with an independent, multistage
area probability sample within each state and the District of
Columbia to produce a nationally representative sample of
67,838 individuals aged 12 years or older. Data from the
2013 NSDUH were used to examine the prevalence and
correlates of tobacco use screening in adolescent respon-
dents (ages 12–17) who reported visiting their physician in
the past year (N = 13,034). For the purpose of these
analyses, only those who responded to questions about
physician screening were included, reducing the sample
to 12,798. A sub-set of this sample who responded to
questions about both physician screening and advice to
quit were used to examine the relationship between
physician tobacco use screening and physician provided
advice to quit (n = 1,868).
Measures
Sociodemographic characteristics
Participants reported sex, age, race/ethnicity, and current
school enrollment. Age was dichotomized as 12–13 years
and 14–17 years to examine differences between early and
late adolescence. Research has shown that an individual’s
income and health insurance coverage impact access to
care and the quality of care received [16, 17]. To examine
how these factors may affect physician screening and ad-
vice to quit, participants’ parents served as proxies to col-
lect information related to income (total family income,
receipt of public assistance, receipt of food stamps) and
health insurance.
Tobacco and substance use
Participants were classified in three mutually-exclusive
groups: never cigarette users, ever cigarette users (but
not in the past 30 days), or past 30-day cigarette users.
Never cigarette users were defined as those who did not
report having ever smoked part or all of a cigarette. Ever
cigarette users were defined as those who reported hav-
ing ever smoked part or all of a cigarette, but not in the
past 30-days. Past 30-day cigarette use was defined as
having smoked part or all of a cigarette on at least one
day in the past 30 days. Additional substance use in-
cluded past 30-day alcohol and marijuana use, which
were defined as having any alcohol or marijuana on at
least one day in the past 30 days, respectively.
Physician screening
Participants were asked one question in regards to phys-
ician screening for tobacco use: “During the past 12 months,
did any doctor or other health care professional ask, either
in person or on a form, if you use tobacco?” Participants
who refused to respond or responded “don’t know” were
excluded from analysis (n = 236). As it is recommended
that physicians screen for all substance use and publicly
available screening tools address multiple substances in the
same screener [18], screening for alcohol and drug use were
also examined. Participants were asked the same question
as it relates to alcohol use and drug use.
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Physician advice to quit
The main outcome considered was whether or not ado-
lescents received advice to quit from their physician. Ad-
vice to quit was assessed with the following question:
“During the past 12 months, did any doctor or other
health care professional advise you to quit smoking ciga-
rettes or quit using any other tobacco products?”.
Data analysis
All analyses were performed using Stata SE13.1 (Stata-
Corp, 2013) and post-stratification weights were used to
offset any non-response or non-coverage bias and pro-
duce nationally representative estimates. Missing data
were handled with listwise deletion per Stata’s survey
procedures. Bivariate analyses examined the prevalence
of physician screening for tobacco use by sociodemographic
characteristics, cigarette use, alcohol use, marijuana use,
and screening for alcohol and marijuana use. Four nested
multivariable logistic regression analyses explored the
relationship between tobacco use screening and phys-
ician advice to quit, controlling for sociodemographic
characteristics in Model A, followed by the addition of
cigarette use in Model B, alcohol use and screening in
Model C, and marijuana use and screening in Model D.
Results
Sample characteristics
Among the adolescents who completed the survey (N =
12,798), 51.7% were female (Table 1). More than two-thirds
(71.7%) of the participants were between the ages of 14 and
17 years old. More than half of adolescents in the sample
were non-Hispanic White (55.5%), 21.9% were Hispanic,
13.8% were non-Hispanic Black, and 5.1% were non-
Hispanic Asian. Approximately 37% of participants had a
total family income of $75,000 or more and more than half
of adolescents (59.6%) had private medical insurance.
Overall, the majority of adolescents reported never
using cigarettes (84.2%). Approximately 10% of adoles-
cents had ever used a cigarette, with 5.6% reporting past
30-day cigarette use. Past 30-day alcohol use (11.5%) was
more common than past 30-day marijuana use (6.9%)
among this sample of adolescents.
Physician screening for tobacco use
Fewer than half of adolescents who visited a physician in
the past 12 months were screened for tobacco use
(49.4%; Table 1). Adolescents who were screened for
tobacco use by their physician were more likely to be
female (56.6%), non-Hispanic White (60.1%), in late
adolescence (83.0%), and covered by private health insur-
ance (63.8%; all p values < .001). Adolescents who were
screened for tobacco use were also more likely to be
screened for alcohol use and drug use (82.6 and 68.3%,
respectively; p values < .001).
Physician advice to quit
Among the adolescents who reported on physician ad-
vice to quit (n = 1,868), the majority were past 30-day
(43.2%; Table 2) and ever smokers (38.5%), followed by
never (18.3%) users. Regardless of cigarette use status,
the majority of adolescents were neither screened for
nor advised to quit tobacco. More than one-third of ever
users (37.7%) and past 30-day users (36.5%) were
screened for tobacco use, but did not receive any advice
to quit. Fewer than one-third of past 30-day users were
screened for tobacco use and received advice to quit
from their physician (26.3%).
In multivariable models, having been screened for to-
bacco use was correlated with a more than 12-fold
higher odds of physician advice to quit, controlling for
sociodemographics (Model A: OR = 12.60, 95% CI 7.98,
19.88 Table 3) and sociodemographics and cigarette use
(Model B: OR = 12.73, 95% CI 8.15, 19.89). In the latter
model, Hispanic ethnicity was correlated with signifi-
cantly lower odds of physician advice to quit smoking
(OR = .48, 95% CI .30, .76). Being male (OR = 1.50, 95% CI
1.07, 2.12) and past 30-day cigarette use (OR = 2.95, 95%
CI 1.73, 5.03) was correlated with a significantly greater
odds of physician advice to quit smoking in this sample.
The relationship between physician tobacco screening
and advice to quit was attenuated, but remained strong
and significant when alcohol use and screening were
added in Model C (OR = 7.12, 95% CI 3.98, 12.74) and
marijuana use and drug screening were added in Model
D (OR = 6.01, 95% CI 3.35, 10.79). In the final model
adjusting for physician screening for tobacco, alcohol,
and drug use, physician screening for tobacco use was
the strongest correlate of receiving physician advice to
quit smoking (OR 6.01; CI 3.35–10.79). In all four models,
Hispanic adolescents were significantly less likely to re-
ceive advice to quit from their physician compared to
non-Hispanic White adolescents.
Discussion
Although 74% of adolescents sampled in the NSDUH re-
ported visiting a physician in the past year, only 49%
were screened for tobacco use by their physician, result-
ing in an estimated 36% of adolescents being screened
for tobacco use at the population level. Only 14.2% of
ever and 26.3% of past 30-day cigarette users were
screened for and received advice to quit tobacco from
their physician. Physician screening for tobacco use was
highly correlated with physician advice to quit smoking,
after controlling for sociodemographic characteristics,
cigarette use, and screening for alcohol use.
The screening and advising rates reported by adoles-
cents in this national study are well below published
clinician reports. In a national survey of US primary care
physicians, Tong et al. found tobacco screening and
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Table 2 Physician interaction by adolescent’s smoking status; NSDUH 2013 (n = 1,868)
Cigarette Use, n (%)
Never Use
342 (18.3)




Neither Screened nor Advised 148 (46.4) 351 (48.2) 266 (37.3)
Only Screened 152 (42.4) 261 (37.7) 302 (36.5)
Screened and Advised 42 (11.1) 108 (14.2) 238 (26.3)
Cell counts reported are unweighted, but the percentages represent the weighted sample. All percentages reported are row percents
Table 1 Descriptive statistics of adolescents by physician tobacco use screening; NSDUH 2013 (n = 12,798)
Overall Physician Screened for Tobacco Use
Yes No P
n = 6324 (49.4%) n = 6474 (50.6%)
Sex, n (%) <.001
Male 6252 (48.3) 2810 (43.4) 3442 (52.7)
Female 6546 (51.7) 3514 (56.6) 3032 (47.2)
Age, n (%) <.001
12–13 yo 3641 (28.3) 1100 (17.1) 2541 (38.8)
14–17 yo 9157 (71.7) 5224 (83.0) 3933 (61.2)
Race/Ethnicity, n (%) <.001
Non-Hispanic White 7255 (55.5) 3872 (60.1) 3383 (51.3)
Non-Hispanic Black 1780 (13.8) 788 (12.1) 992 (15.3)
Hispanic 2449 (21.9) 1089 (20.5) 1360 (23.1)
Non-Hispanic Asian 476 (5.1) 191 (3.8) 285 (6.3)
Non-Hispanic Other 838 (3.8) 384 (3.5) 454 (4.1)
Enrolled in School, n (%) 12683 (99.4) 6262 (99.3) 6421 (99.4) ns
Total Family Income, n (%) <.001
Less than $20,000 2292 (17.5) 1035 (16.2) 1257 (18.7)
$20,000–$49,999 3751 (28.6) 1791 (27.1) 1960 (30.0)
$50,000–$74,999 2236 (16.5) 1089 (16.4) 1147 (16.6)
$75,000 or more 4519 (37.3) 2409 (40.3) 2110 (34.6)
Receives Public Assistance, n (%) 536 (4.0) 237 (3.7) 299 (4.4) <.001
Receives Food Stamps, n (%) 3003 (22.3) 1,362 (20.4) 1641 (24.0) .002
Private Health Coverage, n (%) 7620 (59.6) 3973 (63.8) 3647 (55.7) <.001
Cigarette Use <.001
Never Use 10565 (84.2) 5063 (81.7) 5502 (86.4)
Ever Use, No Current Use 1405 (10.3) 719 (11.1) 686 (9.5)
Current Use (Past 30-Day) 828 (5.6) 542 (7.1) 286 (4.2)
Alcohol, n (%)
Past 30-Day Use 1576 (11.5) 923 (13.5) 653 (9.7) <.001
Screened for Use 5,592 (42.4) 5,187 (82.6) 405 (5.3) <.001
Marijuana, n (%)
Past 30-Day Use 1013 (6.9) 622 (8.8) 391 (5.2) <.001
Screened for Use 4,702 (35.4) 4,339 (68.3) 363 (5.0) <.001
Cell counts reported are unweighted, but the percentages represent the weighted sample. All percentages reported are column percents
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advising rates of 97.7% and 94.9%, respectively [19].
Some may argue that this discrepancy is due in part to
adolescent recall, but evidence indicates that adolescent
recall is more reliable than clinician reports [20, 21]. An-
other potential contributor to the lower rates is the
large non-White population (44.6%) in the study sam-
ple. Similar to the disparities documented in adult pop-
ulations [15, 22–24], we observed lower rates of
screening and counseling among non-White adoles-
cents, particularly Hispanic adolescents.
Lower screening rates have been attributed to both in-
dividual and institutional factors. Physicians report that
brief face-to-face screening and counseling is ineffective,
unpleasant, and that they are ill-prepared for such discus-
sions [19, 25, 26]. Additional barriers have been noted
when working with smokers in underserved communities
including: lack of time, patient unreadiness to change, and
inadequate resources for themselves and their patients
[27]. Rather than physician-focused strategies to overcome
these barriers, arguments have been made for system-level
change as a means of fully integrating tobacco prevention
and cessation in healthcare delivery [12]. Under system-
level recommendations, health care systems would pro-
vide physicians with regular trainings, ensure national and
local resources are made available to physicians and their
patients, and provide feedback to physicians about their
tobacco dependence treatment practices [12].
Certain limitations should be considered when inter-
preting study results. We were unable to make any causal
determinations due to the cross-sectional design of the
Table 3 Multivariable logistic regression models of physician advice to quit smoking among adolescents; NSDUH 2013 (n = 1,886)










Screened for Tobacco 12.60 (7.98, 19.88) <.001 12.73 (8.15, 19.89) <.001 7.12 (3.98, 12.74) <.001 6.01 (3.35, 10.79) <.001
Sex
Female (ref) – – – – – – – –
Male 1.32 (.94, 1.86) ns 1.50 (1.07, 2.12) .021 1.67 (1.19, 2.36) .004 1.60 (1.13, 2.26) .009
Age
12–13 (ref) – – – – – –- – –
14–17 .97 (.41, 2.32) ns .90 (.38, 2.15) ns .79 (.34, 1.84) ns .78 (.35, 1.70) ns
Race
Non-Hispanic White (ref) – – – – – – – –
Non-Hispanic Black .74 (.39, 1.38) ns .81 (.43, 1.53) ns 1.00 (.53, 1.90) ns .95 (.50, 1.79) ns
Hispanic .49 (.31, .76) .002 .48 (.30, .76) .002 .51 (.31, .82) .006 .47 (.28, .78) .004
Non-Hispanic Asian .28 (.03, 2.27) ns .24 (.03, 1.98) ns .28 (.03, 2.37) ns .31 (.04, 2.35) ns
Non-Hispanic Other .84 (.50, 1.41) ns .88 (.52, 1.50) ns .79 (.44, 1.41) ns .75 (.40, 1.41) ns
Family Income
$20,001–$49,999 (ref) – – – – – – – –
Less than $20,000 .97 (.67, 1.40) ns .98 (.67, 1.42) ns .99 (.67, 1.47) ns 1.05 (.69, 1.57) ns
$50,000–$74,999 .93 (.55, 1.55) ns .91 (.53, 1.56) ns 1.00 (.58, 1.72) ns 1.03 (.60, 1.77) ns
$75,000 or More 1.01 (.63, 1.59) ns 1.06 (.65, 1.70) ns 1.17 (.70, 1.96) ns 1.21 (.73, 2.02) ns
Receive Public Assistance 1.25 (.48, 3.31) ns 1.26 (.48, 3.31) ns 1.41 (.56, 3.51) ns 1.43 (.59, 3.46) ns
Receive Food Stamps 1.31 (.83, 2.07) ns 1.30 (.82, 2.05) ns 1.34 (.84, 2.13) ns 1.28 (.81, 2.04) ns
Private Insurance Coverage .65 (.41, 1.02) ns .68 (.41, 1.12) ns .69 (.42, 1.14) ns .67 (.41, 1.82) ns
Cigarette Use
Never Use (ref) – – – – – –
Ever Use, Not Past 30-Day 1.57 (.89, 2.77) ns 1.71 (.97, 3.01) ns 1.82 (1.02, 3.23) .042
Past 30-Day Use 2.95 (1.73, 5.03) <.001 3.43 (2.01, 5.85) <.001 3.65 (2.11, 6.30) <.001
Past 30-Day Alcohol Use .98 (.66, 1.45) ns .89 (.60, 1.31) ns
Screened for Alcohol 2.44 (1.51, 3.97) <.001 1.48 (.82, 2.67) ns
Past 30-Day Marijuana Use 1.18 (.85, 1.63) ns
Screened for Drugs 2.40 (1.41, 4.08) .002
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NSDUH, particularly as it pertains to the diminished
screening rates. Cigarette use was based on the respon-
dent’s status at the time of the survey and may not accur-
ately reflect their cigarette use status at their last physician
visit. Additionally, the self-reported nature of NSDUH may
have resulted in over and under-reporting of behaviors.
Conclusion
Our findings demonstrate low rates of physician tobacco
screening among adolescents and an inadequate provision
of advice to quit to adolescent smokers, despite a strong
relationship between screening and advice to quit. The
discrepancy between screening and advising rates reported
by adolescents in this national study and in published clin-
ician reports underlines the need for more systematic
monitoring and assessment of physician screening and
counseling. Regression analyses revealed that use of and
screening for other substances attenuated the relationship
between screening for tobacco use and advice to quit.
Additional research is needed to identify the best practice
for screening for multiple substances. Our findings also
highlight racial/ethnic disparities in physician screening
and advice to quit, particularly among Hispanic adoles-
cents, not previously reported in the adolescent literature.
This underscores the need for additional resources specific
to these racial/ethnic groups to help facilitate the discus-
sion on tobacco use. Given the critical phase of develop-
ment adolescence poses in tobacco use and the potential
benefit of physician screening and advice to quit during
adolescence, further research is needed to enable physi-
cians to have an open dialogue on tobacco use with their
adolescent patients.
Acknowledgements
At the time of the study, Sabrina L. Smiley was a Scholar with the HIV/AIDS,
Substance Abuse, and Trauma Training Program (HA-STTP), at the University
of California, Los Angeles; supported through an award from the National
Institute on Drug Abuse (R25 DA035692).
Funding
This study was funded by Truth Initiative. The study sponsor did not have
any role in the study design; collection, analysis, and interpretation of data;
writing the report; and the decision to submit the report for publication.
Availability of data and materials
The dataset supporting the conclusions of this article is available through the
National Addiction & HIV Data Archive Program, http://www.icpsr.umich.edu/
icpsrweb/NAHDAP/studies/35509.
Authors’ contributions
LC developed the study, conducted the data analyses, and drafted the
manuscript. SS, RAM, ALG, ACV provided guidance throughout the process
and critical revisions on the manuscript drafts. All authors read and approved
the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
This study was not considered human subjects research under the federal
Common Rule, 45 CFR Part 46 since the dataset was published and publicly
available.
Author details
1Schroeder Institute for Tobacco Research and Policy Studies at Truth
Initiative, 900 G Street, NW, Fourth Floor, Washington, DC, USA. 2Evaluation
Science and Research at Truth Initiative, Washington, DC, USA. 3Department
of Oncology, Georgetown University Medical Center/Cancer Prevention and
Control Program, Lombardi Comprehensive Cancer Center, Washington, DC,
USA. 4Department of Health, Behavior and Society, Johns Hopkins
Bloomberg School of Public Health, Baltimore, MD, USA.
Received: 4 June 2016 Accepted: 22 December 2016
References
1. Sussman S. A lifespan developmental-stage approach to tobacco
and other drug abuse prevention. ISRN Addict. 2013;2013:745783.
doi:10.1155/2013/745783.
2. Graber JA, Brooks-Gunn J. Developmental transitions: linking human
development with tobacco prevention research. Nicotine Tob Res.
1999;1 Suppl 1:S73–7.
3. Abuse S, Administration MHS. Results from the 2013 national survey on
drug use and health: summary of national findings. Rockville: Substance
Abuse and Mental Health Services Administration; 2014.
4. Dierker L, Hedeker D, Rose J, et al. Early emerging nicotine dependence
symptoms in adolescence predict daily smoking in young adulthood. Drug
Alcohol Depend. 2015;151:267–71. doi:10.1016/j.drugalcdep.2015.03.009.
5. Dierker L, Mermelstein R. Early emerging nicotine-dependence symptoms: a
signal of propensity for chronic smoking behavior in adolescents. J Pediatr.
2010;156:818–22. doi:10.1016/j.jpeds.2009.11.044.
6. Dierker L, Swendsen J, Rose J, et al. Transitions to regular smoking and
nicotine dependence in the Adolescent National Comorbidity Survey (NCS-A).
Ann Behav Med. 2012;43:394–401. doi:10.1007/s12160-011-9330-9.
7. Doubeni CA, Reed G, Difranza JR. Early course of nicotine dependence in
adolescent smokers. Pediatrics. 2010;125:1127–33. doi:10.1542/peds.2009-0238.
8. Kann L, Kinchen S, Shanklin SL, et al. Youth risk behavior surveillance-United
States, 2013. MMWR Suppl. 2014;63(4):1–168.
9. Simon P, Kong G, Cavallo DA, et al. Update of adolescent smoking cessation
interventions: 2009–2014. Curr Addict Rep. 2015;2:15–23. doi:10.1007/
s40429-015-0040-4.
10. Stanton A, Grimshaw G. Tobacco cessation interventions for young people.
Cochrane Database Syst Rev. 2013;8:CD003289. doi:10.1002/14651858.
CD003289.pub5.
11. Kottke TE, Battista RN, DeFriese GH, et al. Attributes of successful smoking
cessation interventions in medical practice. A meta-analysis of 39 controlled
trials. JAMA. 1988;259:2883–9.
12. Fiore M, Jaen C, Baker T, et al. Treating tobacco use and dependence: 2008
update. Rockville: U.S. Department of Health and Human Services. Public
Health Service; 2008.
13. Stead LF, Bergson G, Lancaster T. Physician advice for smoking cessation.
Cochrane Database Syst Rev 2008:CD000165. DOI: 10.1002/14651858.
CD000165.pub3.
14. Schauer GL, Agaku IT, King BA, et al. Health care provider advice for
adolescent tobacco use: results from the 2011 National Youth Tobacco
Survey. Pediatrics. 2014;134:446–55. doi:10.1542/peds.2014-0458.
15. Hum AM, Robinson LA, Jackson AA, et al. Physician communication
regarding smoking and adolescent tobacco use. Pediatrics. 2011;127:e1368–74.
doi:10.1542/peds.2010-1195.
16. Devoe JE, Baez A, Angier H, et al. Insurance + access not equal to health
care: typology of barriers to health care access for low-income families. Ann
Fam Med. 2007;5:511–8. doi:10.1370/afm.748.
17. Newacheck PW, Hughes DC, Stoddard JJ. Children’s access to primary care:
differences by race, income, and insurance status. Pediatrics. 1996;97:26–32.
18. National Institute on Drug Abuse. Resource Guide: Screening for Drug Use
in General Medical Settings. Available at: https://www.drugabuse.gov/
publications/resource-guide-screening-drug-use-in-general-medical-settings/
nida-quick-screen Accessed 10 Nov 2016.
Collins et al. Tobacco Induced Diseases  (2017) 15:2 Page 6 of 7
19. Tong EK, Strouse R, Hall J, et al. National survey of U.S. health professionals’
smoking prevalence, cessation practices, and beliefs. Nicotine Tob Res. 2010;
12:724–33. 10.1093/ntr/ntq071.
20. Klein JD, Allan MJ, Elster AB, et al. Improving adolescent preventive care in
community health centers. Pediatrics. 2001;107:318–27.
21. Klein JD, Wilson KM. Delivering quality care: adolescents’ discussion of
health risks with their providers. J Adolesc Health. 2002;30:190–5.
22. Nugent CN, Schoenborn CA, Vahratian A. Discussions between health care
providers and their patients who smoke cigarettes. NCHS data brief, no 174.
Hyattsville: National Center for Health Statistics; 2014.
23. Browning KK, Ferketich AK, Salsberry PJ, et al. Socioeconomic disparity in
provider-delivered assistance to quit smoking. Nicotine Tob Res. 2008;10:55–61.
doi:10.1080/14622200701704905.
24. Cokkinides VE, Halpern MT, Barbeau EM, et al. Racial and ethnic disparities in
smoking-cessation interventions: analysis of the 2005 National Health
Interview Survey. Am J Prev Med. 2008;34:404–12. doi:10.1016/j.amepre.
2008.02.003.
25. Vogt F, Hall S, Marteau TM. General practitioners’ and family physicians’
negative beliefs and attitudes towards discussing smoking cessation with
patients: a systematic review. Addiction. 2005;100:1423–31. doi:10.1111/j.
1360-0443.2005.01221.x.
26. Horvath KJ, Eastman M, Prosser R, et al. Addressing smoking during medical
visits: patients with human immunodeficiency virus. Am J Prev Med. 2012;
43:S214–21. doi:10.1016/j.amepre.2012.07.032.
27. Blumenthal DS. Barriers to the provision of smoking cessation services
reported by clinicians in underserved communities. J Am Board Fam Med.
2007;20:272–9. doi:10.3122/jabfm.2007.03.060115.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Collins et al. Tobacco Induced Diseases  (2017) 15:2 Page 7 of 7
